CMS Entry id: 2709 | Channel: Blog landing page | Template: blog/index

Login
Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin

Blog

CANTAB tests predict functional decline in patients with amnestic mild cognitive impairment

We presented a novel, predictive model of functional decline at CTAD 2018. The model suggests that CANTAB PAL and SWM provide essential screening information when recruiting patients with amnestic mild cognitive impairment into Alzheimer’s disease clinical trials.

Using Bayesian methods to model normative CANTAB cognitive performance across adulthood

At CTAD 2018 we shared our new data on why a Bayesian approach is best to describe normative cognitive performance, especially when making scientifically robust comparisons to neurologically impaired groups. 

Using CANTAB to investigate age-related cognitive changes associated with dementia in Down syndrome

PhD researcher, Rosalyn Hithersay, spoke to us about her recent publication on which cognitive tests are most sensitive to the early stages of dementia in Down syndrome.

Neural Network classification of longitudinal cognitive data for prediction of individual-level chan

For the first time, Neural Network classifiers have been applied to changes in CANTAB PAL performance between baseline and 10 months to accurately predict the development of MCI at 20 months. Dr Elizabeth Baker, Statistical Scientist at Cambridge Cognition, presented the novel findings at AAIC 2018

Revolutionising the detection of cognitive impairment in patients with multiple sclerosis

Cognitive dysfunction is a leading cause of disability in multiple sclerosis (MS), yet practical restraints mean it often goes unassessed in routine clinical care. Promising new research, published in Frontiers in Neurology, suggests the Cambridge Neuropsychological Test Automated Battery (CANTAB) may offer a brief and sensitive technological solution.

Comparing visuospatial associative learning for a middle-aged birth cohort and patients with schizop

Visuospatial memory is extremely heterogeneous in schizophrenia. In a large population study, around a fifth of patients with schizophrenia showed similar errors rates to the top 50% of the general population. Conversely, half of the patients sampled showed substantial impairments. 

The CANTAB Paired Associates Learning task as a pre-screening tool for clinical trials

Enriching participant eligibility for clinical trials through pre-screening for cognitive deficit.

web-based testing, wearables, voice recognition, virtual research, virtual clinical trials, technology, swm, subjective measures, stigma, social cognition, soc, smartphones, schizophrenia research, schizophrenia, research funding, remote testing, regulations, recruitment, real-world assessments, prodromal, pro-cognitive, presenteeism, preclinical, precision psychiatry, pre-clinical, physical health, personalised medicine, patient-centric, patient recruitment, patient finding, parkinson's disease, pal, ots, opinion piece, occupational health, objective measures, normative data, neurotech, neuroscience, near-patient testing, multiple sclerosis, ms, modelling, modafinil, mental wellbeing, mental health, mci, major depression, lifespan, innovate uk, ied, icosr, high frequency, healthcare, ert, epidemiology, emotion recognition, ecological momentary assessments, ebt, ebbinghaus, early alzheimer's disease, drug development, digital tools, digital health, diagnosis, depression, dementia, computerised testing, cognitive testing, cognitive science, cognitive safety, cognitive impairment, cognitive function, cognitive dysfunction, cognitive deficits, cognitive biomarkers, cognitive assessment, cognition kit, cognition, cns summit, clinical trials, clinical trial, cias, chronic pain, cgt, cantab research grant, cantab for clinical trials, cantab, brain health, brain donor program, biomarkers, awards, automatic speech recognition, autism, attention, at-home testing, asd, alzheimer's disease, affective cognition, absenteeism,